NCT06661980 - Dexmedetomidine on Brain Injury Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 15, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

December 1, 2025

Conditions

Brain Injuries

Interventions

DRUG

Dexmedetomidine Injectable Solution

Dexmedetomidine 200 mcg/ 2 mL IV.

OTHER

Placebo

Normal Saline IV.

Trial Locations (1)

RECRUITING

Damanhour Teaching Hospital, General Organization for Teaching Hospitals and Institutes., Damanhūr

All Listed Sponsors

collaborator

Tanta University

OTHER

lead

Damanhour University

OTHER